“Contact Us Before DEA or…”
PharmaDiversion, LLC
1167 West Baltimore Pike, Suite 231
Media, PA 19063
e-mail: Carlos@pharmadiversion.com
DETERMINING REQUIRED SERVICE LEVEL
PharmaDiversion is committed to establishing a long lasting and trusted relationship with our clients. Whether you are a small business owner seeking the guidance of a regulatory professional, or a department head for a Fortune 100 pharmaceutical firm, PharmaDiversion will be a partner you can rely on to guide you as you prepare your facility for an unannounced DEA inspection. We have a service level to meet your company’s needs.
Pharmacies
PharmaDiversion will work with you and your staff to ensure that you are in compliance with all DEA guidelines and regulatory statutes.
READ MOREIn-service Training
PharmaDiversion can provide in-service training at your facility in a formal or informal setting.
READ MOREPhysician Offices
PharmaDiversion will advise on DEA guidelines and regulatory statutes related to controlled substance storage, handling and reporting.
READ MORENarcotics Treatment Facilities
PharmaDiversion consults on DEA regulatory statutes related to controlled substance storage, handling and reporting.
READ MOREManufacturers & Distributors
PharmaDiversion will work with you and your staff to ensure that you are in compliance with the DEA.
READ MOREChemical Import / Export
PharmaDiversion ensures compliance with DEA IMPORT/EXPORT of List I and List II regulated chemicals.
READ MOREUnique Qualifications
An energetic and results oriented professional with over twenty-eight years of experience with DEA regulatory enforcement and successfully maintaining a high level of customer satisfaction.
Skilled in interpreting the Controlled Substances Act (CSA) and Title 21, Code of Federal Regulations (21CFR) for registrants wanting to meet those requirements imposed by these laws and regulations that are enforced by DEA personnel.
Regulatory enforcement by DEA will focus on DEA required records, the security of controlled substances and the “Due Diligence” placed on a registrant to know their customers. Failure to maintain complete and accurate records, inventory, security of controlled substances and the lack of a “Due Diligence” program may result in administrative and civil actions on their DEA registration.